相关实验视频
Updated: Jun 9, 2025
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.1K
普雷加巴林用于治疗神经病痛:对患者报告结果的系统审查
Zhihui Wang1,2, Iffat Naeem1, Tinu Oyenola1
1Research, Health Research Partners, Calgary, CAN.
Cureus
|October 30, 2024
概括
普雷加巴林有效地改善神经病痛患者的睡眠和生活质量. 然而,它对焦虑和抑郁等心理健康结果的影响仍然不一致,需要进一步调查.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 神经病变性疼痛 (NeP) 显著影响患者的功能和生活质量.
- 普雷加巴林是NeP的主要治疗方法,但患者报告的结果 (PRO) 尚未得到充分研究.
- 在临床测量之外,PRO提供了对治疗有效性的关键见解.
研究的目的:
- 系统地审查从研究中获得的关于NeP的普雷加巴林的PROs.
- 评估普雷加巴林对睡眠障碍,心理健康和与健康相关的生活质量 (HRQOL) 的影响.
- 从以患者为中心的角度综合关于普雷加巴林疗效的证据.
主要方法:
- 按照Cochrane协作指南进行系统的文献搜索.
- 包括随机对照试验和流行病学研究报告PROs.
- 来自16项选定的研究数据的叙述综合.
主要成果:
- 普雷加巴林在睡眠干扰和HRQOL方面显著改善.
- 高剂量 (≥300 mg/天) 与更大的HRQOL益处有关.
- 心理健康结果 (焦虑,抑郁) 在研究中显示出不一致的改善.
- 结果的异质性阻止了元分析.
结论:
- 普雷加巴林有效地缓解了与NeP相关的睡眠障碍,并增强了HRQOL.
- 这种药物对NeP患者心理健康的影响需要进一步研究.
- 一个全面的NeP治疗策略应该将临床数据与患者报告的结果整合起来.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:25Analgesia and Pain Management
534
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
534
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
258
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
258
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
336
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
336
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149